Overview: A Shift in How Menopause Hormone Therapy Is Labeled The FDA has announced a major update to the labeling of menopause hormone therapies, removing the long-standing black box warnings about potential risks such as breast cancer, heart disease, and dementia. The change aims to provide clearer, more balanced information to patients and clinicians, emphasizing…